← Evidence map

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study.

Kala Visvanathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

60 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 27870562